Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer

Table 1 Clinical and pathologic information of training set, test set and entire set

Character	Training set		Test set		Entire set
Character	Number	%	Number	%	Number	%
Risk score
Median	0.994441		0.843157		0.925682
Range	0.074169–5.458149		0.186167–2.964505		0.074169–5.458149
Age
Median	65		64		65
Range	35–85		39–88		35–88
Gender
Male	65	55.08	28	52.83	93	54.39
Female	53	44.92	25	47.17	78	45.61
AJCC_stage
I + II	112	94.92	52	98.11	164	95.91
III + IV	6	5.08	1	1.89	7	4.09
Grade
G1 + G2	88	74.58	33	62.26	121	70.76
G3 + G4	30	25.42	20	37.74	50	29.24
T
T1 + T2	20	16.95	10	18.87	30	17.54
T3 + T4	98	83.05	43	81.13	141	82.46
N
N0 + NX	37	31.36	13	24.53	50	29.24
N1	81	68.64	40	75.47	121	70.76
M
M0 + MX	115	97.46	52	98.11	167	97.66
M1	3	2.54	1	1.89	4	2.34

ISSN: 1475-2867